Literature DB >> 25214161

Preventive intervention for iron deficiency anaemia in a high risk population.

Lutfi Jaber1.   

Abstract

BACKGROUND: Iron deficiency anaemia (IDA) is a common nutritional problem.
OBJECTIVE: To determine the effect of nutritional education and supplemental iron administration on the prevalence of IDA in Arab infants.
METHODS: Three hundred and ten infants were randomized alternately into two groups. Mothers (n = 143) in the control group received standard information on prevention of IDA and mothers in the intervention group (n = 144) received extensive information on the importance of an iron-rich diet. Data was scored regarding diet contents. Mothers in the intervention group were encouraged to give their children an iron polymaltose complex (IPC) preparation starting from age 4 months to 1 year. Compliance of receiving the medication was evaluated. The groups were compared for outcome by chi-square test. Main outcome measures were haemoglobin (Hb), mean corpuscular volume (MCV), and serum ferritin levels.
RESULTS: Anaemia (Hb <11 g/dL) was recorded in 28% and 34% of the intervention and control groups, respectively (p = NS). There was no effect of infant or parental background factors on rate of anaemia. Frequency of anaemia was lower in infants who received ≥ 6 months of iron medication according to mothers' reports, and in infants breastfed for ≥ 6 months (p = 0.002).
CONCLUSIONS: Questions were raised regarding the strategies of preventing IDA in infancy.

Entities:  

Keywords:  Iron deficiency of infancy; ferrous gluconate; ferrous sulfate; iron absorption; polymaltose complex

Mesh:

Substances:

Year:  2014        PMID: 25214161     DOI: 10.3233/JRS-140622

Source DB:  PubMed          Journal:  Int J Risk Saf Med        ISSN: 0924-6479


  1 in total

1.  Use of iron supplements in children aged 1-2 years with iron deficiency anemia: A cross-sectional study.

Authors:  Handan Atsiz Sezik; Huseyin Can; Mehmet Ali Kurnaz; Mine Tuna; Zeynep Ay
Journal:  Pak J Med Sci       Date:  2015 Sep-Oct       Impact factor: 1.088

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.